Clinical Trial Update: A Safety and Efficacy Study of Infliximab (Remicade) in Patients With Plaque Type Psoriasis [Phase 2]

View source ↗

Summary

Phase 2 safety and efficacy study of infliximab (Remicade) in patients with plaque psoriasis completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Infliximab (Remicade) (Infliximab)

Snippet

Sponsor: Centocor, Inc. | Conditions: Psoriasis | Phase 2 | Status: COMPLETED